COP CompuGroup Medical SE & Co. KGaA

EQS-News: CompuGroup Medical successfully completes share buyback program

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Share Buyback
CompuGroup Medical successfully completes share buyback program

29.04.2024 / 14:49 CET/CEST
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical successfully completes share buyback program

  • Target reached before expiration date
  • Company acquires 500,000 shares
  • Volume of EUR 14.6 million

Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) has ended its share buyback program successfully on April 26 shortly before the expiration date. The target of a maximum of 500,000 shares to be acquired was reached last Friday. The volume acquired corresponds to approximately 0.93% of the Company´s share capital. The company announced the start of the program on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on March 26, 2024.

The weighted average price per share acquired was EUR 29.26, the total volume of the buyback was EUR 14.6 million. The general partner of CGM had granted a volume of up to EUR 15.5 million for the buyback.

CFO Daniela Hommel said: "We are pleased with the successful share buyback. By acquiring own shares we are confirming our confidence in the future of our company and are expanding our options for further strategic development."

The shares were purchased exclusively via the Frankfurt Stock Exchange (XETRA trading) by a bank commissioned by CGM. The Company's own shares acquired through the buyback program can be used for any purpose permitted under the authorization granted by the Annual General Meeting on May 19, 2021.

Further information on the share buyback program and the upcoming virtual Annual General Meeting on 22 May can be found on the website at .



29.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail:
Internet:
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1891987

 
End of News EQS News Service

1891987  29.04.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1891987&application_name=news&site_id=research_pool
EN
29/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CompuGroup Medical SE & Co. KGaA

Aurelien Sivignon
  • Aurelien Sivignon

CompuGroup Medical SE : Little clarity in the medium-term outlook. Neu...

>Conference call feedback: 2024 guidance confirmed but no indication on medium-term prospects after the abandonment (unsurprisingly) of the 2025 targets - CompuGroup published yesterday morning a soft Q1 2024, slightly below expectations (first take link published yesterday). Below are the main elements from the conference call: 1/ 2024 guidance confirmed with a more favourable base effect in H2. As anticipated, the momentum in H1 has been penalised by the base effec...

Aurelien Sivignon
  • Aurelien Sivignon

CompuGroup Medical SE : Peu de lisibilité sur les perspectives MT. Opi...

>Feedback conf. call : guidance 2024 confirmée mais aucune indication sur les perspectives MT après l’abandon (sans surprise) des objectifs 2025 - CompuGroup a publié hier matin un T1 2024 soft et légèrement en deçà des attentes (lien first take publiée hier). Ci-dessous les principaux éléments que nous retenons de la conférence call : 1/ Guidance 2024 confirmée avec un effet de base plus favorable au S2. Comme anticipé, la dynamique du S1 est pénalisée par l’effet d...

Gerardo Ibanez ... (+2)
  • Gerardo Ibanez
  • Steven Boumans

ODDO BHF Small & MIDCAP MORNING NEWS - 05/08/2024 Date Performance sin...

Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch